Bioscience Americas' Researcher to Address International Stem Cell Conference
(PRWEB) March 18, 2016 -- Bioscience Americas, LLC (http://www.bioscienceamericas.com), a leading international developer of autologous stem cell therapy centers for the treatment of autoimmune diseases, is pleased to announce that its lead scientific researcher, Dr. Anand Srivastava, has been invited to speak at the Fifth Annual European Biosimilar Conference to be held in Valencia, Spain, June 27-29, 2016.
Dr. Srivastava will speak on the dynamic world of stem cell research and the progress being made by Bioscience Americas’ research partner, the Global Institute of Stem Cell Therapy and Research. The Global Institute is the leader in the field of adult stem cell research and has devoted the last fifteen years and more than $400 million in creating treatments for many of the world’s most devastating diseases. Dr. Srivastava is recognized as being a pioneer in the field and is among its leaders.
Euro Biosimilars 2016 is a three-day event that brings together more than 300 top scientists and researchers in the biologic sector. Representatives from research organizations, top universities, and biopharmaceutical companies will be in attendance. The goal of the conference is to bring together the preeminent minds in the field to foster learning and research.
In commenting on the invitation, Bioscience Americas’ CEO Eric Stoffers said, “Dr. Srivastava’s participation is a feather in our cap. We are pleased to be associated with him and the Global Institute team.”
In other news, Bioscience Americas has been granted an exclusive license from the Global Institute to develop adult stem cell treatment centers in Central America including Costa Rica. Costa Rica is well known as a major medical tourism destination for patients from North America and Europe. Bioscience Americas President Bill Deegan said that the company has initiated discussions with medical institutions in Costa Rica with the expectation of creating recognized treatment affiliations.
Bioscience Americas currently has under development a stem cell clinic in Rio Negro, Colombia, to be affiliated with San Vicente Hospital, South America’s leading organ transplant hospital.
In addition to its expansion into Central America, Bioscience Americas has an exclusive to develop medical stem cell facilities throughout South America to treat local patients as well as patients obtained through its medical tourism efforts.
The Global Institute of Stem Cell Therapy and Research is a consortium of research scientists from throughout the world. It is based at the University of California Medical Center in San Diego.
Bioscience Americas is the joint venture partner of the Global Institute. Its mission is to bring the therapies created in the lab to the marketplace. Bioscience Americas is based in Phoenix, Arizona.
Bill Deegan, Bioscience Americas, LLC, http://www.bioscienceamericas.com, +1 888-623-0337, [email protected]
Share this article